Männedorf, Switzerland, May 5, 2022 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend the following conferences for institutional investors in the upcoming weeks: Berenberg Diagnostics Conference 2022, London, UKDate: 10 May 2022, Panel Discussion 12:00 pm BST (1:00 pm CEST)Presenter: Dr. Achim von Leoprechting, CEO, Tecan No webcastHosting additional investor meetings UBS Pan European Small and Mid-Cap Conference, London, UKDate: 11 May 2022Participants: Dr. Achim
Votes cast exclusively through the independent proxy in line with COVID-19 Ordinance 3 of the Swiss government to combat the pandemicIncrease in the dividend from CHF 2.30 to CHF 2.80 per shareMyra Eskes elected as new member of the Board of DirectorsLukas Braunschweiler, Heinrich Fischer, Oliver Fetzer, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of DirectorsLukas Braunschweiler confirmed by shareholders as Chair of the BoardChrista Kreuzburg, Oli
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Financial results for the full year 2021 – Highlights Sales of CHF 946.6 million (2020: CHF 730.9 million) Growth of 29.5% in Swiss francs or 29.6% in local currenciesOrganic growth of 14.0% in Swiss francs or 14.1% in local currencies Reported operating profit before depreciation and amortization (EBITDA) of CHF 204.6 million (2020: CHF 159.1 million), including transaction and acquisition-related costs Repo